Evolvere BioSciences

Antibiotics are increasingly failing because bacteria rapidly evolve drug resistance, creating a growing global health crisis.

The company uses AI and co-evolutionary protein–protein interaction data to predict bacterial mutations and design next-generation, targeted “future-proof” antibiotics.

Pharmaceutical companies and healthcare providers developing and using new antibiotics to treat resistant bacterial infections.